Showing 8841-8850 of 20877 results for "".
AI and Hair Loss: Measuring Progress with Data-Driven Insights
https://reachmd.com/programs/clinicians-roundtable/ai-and-hair-loss-measuring-progress-with-data-driven-insights/32933/Explore how devices powered by artificial intelligence can impact the way dermatologists track hair loss through precise data.Next-Gen Clinical Monitoring: Predicting Inpatient Decline with AI-Driven Alerts
https://reachmd.com/programs/the-convergence/clinical-monitoring-inpatient-decline-ai-alerts/39924/An artificial intelligence (AI)-driven clinical alert model has the potential to reshape inpatient care by detecting early signs of deterioration an average of 17 hours before adverse events occur. Dr. Brian McDonough sits down with Dr. Theodoros Zanos, to learn more about how his team combined contManaging AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
https://reachmd.com/programs/project-oncology/akt-inhibitor-ae-hr-positive-her2-negative-advanced-bc/54763/In HR+/HER2- advanced breast cancer, effective management of AKT inhibitor-associated adverse events (AEs) begins well before treatment initiation. To learn more about how proactive planning and patient-centered strategies can help reduce the risks of hyperglycemia, rash, and diarrhea, Dr. Charles TThe Role of Neuromodulators in Treating IBS
https://reachmd.com/programs/gi-insights/the-role-of-neuromodulators-in-treating-ibs/28871/Here’s how neuromodulators can help provide symptom relief for patients with irritable bowel syndrome.How to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
https://reachmd.com/programs/clinicians-roundtable/increase-alpha-1-antitrypsin-deficiency-testing/49233/Despite decades of guideline recommendations, only a small fraction of patients with alpha-1 antitrypsin deficiency are ever diagnosed. Here with Dr. Brian McDonough to share real-world strategies for improving testing rates is Dr. Brooks Kuhn, Associate Professor of Medicine and Medical Director ofTargeting BAFF and APRIL in IgA Nephropathy
https://reachmd.com/programs/frontlines-iga-nephropathy/baff-april-iga-nephropathy/60616/Advances in our understanding of BAFF and APRIL biology are reshaping the treatment landscape for IgA nephropathy (IgAN), with dual pathway inhibition emerging as a promising disease-modifying strategy. Joining Dr. Gates Colbert for a conversation about the rationale, clinical potential, and remainiThe Inflammatory Drivers of Itch in Atopic Dermatitis
https://reachmd.com/programs/dermconsult/inflammatory-drivers-itch-atopic-dermatitis/60648/Itch is the defining symptom of atopic dermatitis and a major driver of patient burden and treatment satisfaction. Given that, Dr. Brian Kim joins us to examine the inflammatory mechanisms underlying itch, highlighting the roles of cytokines such as IL-4, IL-13, and IL-31 in activating sensory neuroBeyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
https://reachmd.com/programs/project-oncology/unmet-needs-nsclc/49143/Advances in targeted therapies have dramatically improved outcomes for patients with ALK-positive non-small cell lung cancer, but new resistance challenges continue to emerge. In this episode, Dr. Urs Weber discusses how cancers adapt to treatment, why off-target resistance and histologic transformaINTEGUMENT-OLE and What’s Next for Pediatric AD
https://reachmd.com/videos/skin-minute/integument-ole-study/56899/Pediatric dermatologist Larry Eichenfield, MD, talks about the INTEGUMENT-OLE study data and the impact of the roflumilast cream 0.05% (Zoryve) on the treatment of mild-to-moderate atopic dermatitis in children aged 2 to 5 years.Preventing Sjögren’s Complications: The Importance of Timely, Accurate Diagnosis
https://reachmd.com/programs/living-rheum/preventing-sjogrens-complications-the-importance-of-timely-accurate-diagnosis/36347/Delayed recognition of Sjögren’s disease can lead to serious complications, including interstitial lung disease, lymphoma, and renal involvement. That's why awareness of these diverse manifestations can improve diagnostic accuracy, prevent irreversible damage, and support timely, comprehensive care.